Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo

Artificial Cells, Nanomedicine and Biotechnology

Volumn 42, Issue 3, 2014, Pages 161-166

  Han, Cuiyan ^a,b   Li, Yao ^b   Sun, Mingshuang ^a   Liu, Chang ^b   Ma, Xiaoxing ^b   Yang, Xinggang ^a   Yuan, Yue ^a   Pan, Weisan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

AEYLR peptide; Cy7; DiR; EGFR; Nanostructured lipid carriers; Near infrared fluorescent imaging; Tumor targeting

Indexed keywords

BIOLOGICAL MATERIALS; CHEMOTHERAPY; FLUORESCENCE; INFRARED DEVICES; MAMMALS; PEPTIDES;

CY7; DIR; EGFR; NANOSTRUCTURED LIPID CARRIERS; NEAR-INFRARED FLUORESCENT; TUMOR TARGETING;

TUMORS;

1,1' DIOCTADECYLTETRAMETHYL INDOTRICARBOCYANINE IODIDE; ALANYLGLUTAMYLTYROSYLLEUCYLARGININE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUORESCENT DYE; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PEPTIDE; UNCLASSIFIED DRUG; 1,1'-DIOCTADECYL-3,3,3',3'-TETRAMETHYLINDOTRICARBOCYANINE; CARBOCYANINE; DRUG CARRIER; LIGAND; LIPID; NANOMATERIAL; OLIGOPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN LOCALIZATION; PROTEIN TARGETING; TUMOR XENOGRAFT; ZETA POTENTIAL; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG RELEASE; GENE EXPRESSION REGULATION; METABOLISM; TISSUE DISTRIBUTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; DRUG CARRIERS; DRUG LIBERATION; ERBB RECEPTORS; FEASIBILITY STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LIPIDS; MICE; NANOSTRUCTURES; OLIGOPEPTIDES; TISSUE DISTRIBUTION;

EID: 84900990436     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2013.801848     Document Type: Article

References (36)

1. Ahles TA, Saykin AJ. 2007. Candidate mechanisms for chemotherapyinduced cognitive changes. Nat Rev Cancer. 7:192-201.
2. Almiñana N, Polo D, Rodríguez L, Reig F. 2004. Biodistribution study of doxorubicin encapsulated in liposomes: influence of peptide coating and lipid composition. Prep Biochem Biotechnol. 34:77-96.
3. Basile L, Pignatello R, Passirani C. 2012. Active targeting strategies for anticancer drug nanocarriers. Curr Drug Deliv. 9:255-268.
4. Bondì ML, Craparo EF, Giammona G, Cervello M, Azzolina A, Diana P, et al. 2007. Nanostructured lipid carriers-containing anticancer compounds:preparation,characterization,and cytotoxicity studies. Drug Deliv. 14:61-67.
5. Cho H, Indig GL, Weichert J, Shin HC, Kwon GS. 2012. In vivo cancer imaging by poly(ethyleneglycol)-b-poly(-caprolactone) micelles containing a near-infrared probe. Nanomedicine. 8:228-236.
6. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP. 1991. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51: 2164-2172.
7. Gao J, Yu Y, Zhang Y, Song J, Chen H, Li W, et al. 2012. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials. 33:270-282.
8. Grünwald V, Hidalgo M. 2003. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Nati Cancer Inst. 95:851-867.
9. Han CY, Li Y, Sun MS, Liu C, Ma XX, Yang XG, et al. 2013. A novel small peptide as a epidermal growth factor receptor targeting ligand for nanodelivery in vitro. Int J Nanomedicine 8:1541-1549.
10. Han RL, Yang YM, Dietrich J, Luebke A, Mayer-Pröoschel M, Noble M. 2008. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Boil. 7:12-33.
11. Hara T, Bhayana B, Thompson B, Kessinger CW, Khatri A, McCarthy JR, et al. 2012. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardivvasc Imaging. 5:607-615.
12. Hwang SY, Cho DY, Kim HK, Cho SH, Yoon WJ, Lee EK. 2010. Preparation of targeting proteoliposome by post insertion of a linker molecule conjugated with recombinant human epidermal growth factor. Bioconjug Chem. 21:345-351.
13. Jia LJ, Shen JY, Zhang D, Duan C, Liu G, Zheng D, et al. 2012. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol. 50:523-529.
14. Jie LY, Cai LL, Wang LJ, Ying XY, Yu RS, Zhang MM, Du YZ. 2012. Actively- targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging. Int J Nanomedicine. 7:3981-3989.
15. Johnstone RW, Ruefli AA, Lowe SW. 2002. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153-164.
16. Kircher MF, Weissleder R, Josephson L. 2004. A dual fluorochrome probe for imaging proteases. Bioconjugate Chem. 15:242-248.
17. Li F, Weng Y, Wang L, He H, Yang J, Tang X. 2010. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. Int J Pharm. 393:204-212.
18. Liu D, Liu Z, Wang L, Zhang C, Zhang N. 2011. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerfaces. 85:262-269.
19. Liu DH, Liu FX, Liu ZH, Wang LL, Zhang N. 2011. Tumor specific delivery and therapy by double-targeted nanostructured lipid carriers with anti-VEGFR-2 antibody. Mol Pharm. 8:2291-2301.
20. Liu FS. 2009. Mechanisms of chemotherapeutic drug resistancein cancer therapy-a quick review. Taiwan J Obstet Gynecol. 48:239-244.
21. Li ZH, Zhao RJ, Wu XH, Sun Y, Yao M, Li JJ, et al. 2005. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 19:1978-1985.
22. Li Z, Wu L, Hu P, Han S, Zhang T, Fan H, et al. 2012. Soft nanomaterialbased targeting polymersomes for near-infrared fluorescence multispectral in vivo imaging. Nanoscale. 4:7097-7105.
23. Malam Y, Loizidou M, Seifalian AM. 2009. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci. 30:592-599.
24. Marcucci F, Lefoulon F. 2004. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress. Drug Discov Today. 9:219-228.
25. Meghna T, Jackie K, William D, Sanjay G. 2011. Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs. 22:949-962.
26. Pan XG, Wu G, Yang WL, Barth RF, Tjarks W, Lee RJ. 2007. Synthesis of cetuximab- immunoliposomes via a cholesterol-based membrane anchor for targeting of EGFR. Bioconjug Chem. 18:101-108.
27. Saha RN, Vasanthakumar S, Bende G, Snehalatha M. 2010. Nanoparticulate drug delivery systems for cancer chemotherapy. Mol Membr Biol. 27:215-231.
28. Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, et al. 2011. Effect of octreotide- polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostured lipid carrier loaded with hydroxycamptothecine. Mol Pharm. 8:1641-1651.
29. Torchilin VP. 2007. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J. 9:E128-E147.
30. Tseng CL, Su WY, Yen KC, Yang KC, Lin FH. 2009. The use of biotinylated- EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials. 30:3476-3485.
31. Wu Y, Cai W, Chen X. 2006. Near-infrared fluorescence imaging of tumorintegrin ?v?3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol. 8:226-236.
32. Yang CR, Zhao XL, Hu HY, Li KX, Sun X, Li L, Chen DW. 2010. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers. Chem Pharm Bull. 58:656-661.
33. Zhang XX, Gan Y, Gan L, Nie SF, Pan WS. 2008. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer. J Pharm Pharmacol. 60:1077-1087.
34. Zhang Y, Zhang YF, Bryant J, Charles A, Bryant J, Charles A. 2004. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res. 10:3667-3677.
35. Zhao X, Zhao Y, Geng L, Li X, Wang X, Liu Z, et al. 2011. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography- mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. J Chromatogr B. 879:3721-3727.
36. Zhou H, Zou P, Chen ZC, You Y. 2007. A novel vicious cycle cascade in tumor chemotherapy. Med Hypotheses. 69:1230-1233.